Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1872]
News [4281]
Articles [400]
Editorials [10]
Conferences [107]
elearning [41]
Genomic signatures and predictive biomarkers in breast cancer
Dr Charles Swanton - Cancer Research UK, London, UK
Genomic signatures and predictive biomarkers in breast cancer ( Dr Charles Swanton - Cancer Research UK, London, UK )
19 Apr 2013
Next generation PI3 kinase inhibition
Dr Maurizio Scaltriti – Massachusetts General Hospital, Boston, MA, US
Next generation PI3 kinase inhibition ( Dr Maurizio Scaltriti – Massachusetts General Hospital, Boston, MA, US )
19 Apr 2013
Genome-wide methylation patterns suggest differences in breast cancer biology...
Dr Christine Ambrosone - The Roswell Park Cancer Institute, Buffalo, USA
Genome-wide methylation patterns suggest differences in breast cancer biology in American women of African and European ancestry ( Dr Christine Ambrosone - The Roswell Park Cancer Institute, Buffalo, USA )
19 Apr 2013
Sapacitabine and seliciclib, antitumour activity in patients with incurable...
Dr Geoffrey Shapiro - Dana-Farber Cancer Institute, Boston, USA
Sapacitabine and seliciclib, antitumour activity in patients with incurable BRCA-deficient cancers ( Dr Geoffrey Shapiro - Dana-Farber Cancer Institute, Boston, USA )
8 Apr 2013
The Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer...
Dr Chaya Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA
The Childhood Cancer Survivor Study (CCSS) and the Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study ( Dr Chaya Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA )
17 Dec 2012
Neurocognitive impact in adjuvant chemotherapy for breast cancer
Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor...
Neurocognitive impact in adjuvant chemotherapy for breast cancer ( Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor, USA )
17 Dec 2012
Predicting late distant metastases in ER / HER2- breast cancer patients
Dr Peter Dubsky - Medical University of Vienna, Austria
Predicting late distant metastases in ER / HER2- breast cancer patients ( Dr Peter Dubsky - Medical University of Vienna, Austria )
17 Dec 2012
Investigation of Ki67 biomarker
Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada
Investigation of Ki67 biomarker ( Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada )
17 Dec 2012
Results of a randomised phase 2 study of PD 0332991
Dr Richard Finn - Universtity of California, Los Angeles, USA
Results of a randomised phase 2 study of PD 0332991 ( Dr Richard Finn - Universtity of California, Los Angeles, USA )
17 Dec 2012
Eribulin fails to demonstrate superiority over capecitabine in advanced breast...
Dr Peter Kaufman – Norris-Cotton Cancer Center, Lebanon, USA
Eribulin fails to demonstrate superiority over capecitabine in advanced breast cancer ( Dr Peter Kaufman – Norris-Cotton Cancer Center, Lebanon, USA )
16 Dec 2012
Mammographic density and the risk and detection of breast cancer
Dr Norman Boyd – University of Toronto, Canada
Mammographic density and the risk and detection of breast cancer ( Dr Norman Boyd – University of Toronto, Canada )
16 Dec 2012
Validation of genomic grade index histological grading in invasive breast cancer
Prof Christos Sotiriou – Jules Bordet Institute, Brussels, Belgium
Validation of genomic grade index histological grading in invasive breast cancer ( Prof Christos Sotiriou – Jules Bordet Institute, Brussels, Belgium )
16 Dec 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation